Advertisement
Screener

THE PENNANT GROUP, INC. (PNTG) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

THE PENNANT GROUP, INC. Cash Flow Breakdown

Cash flow breakdown shows where THE PENNANT GROUP, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $48.29M came in.
  • Fiscal year ended 2025-12-31: from investing, $227.97M went out.
  • Fiscal year ended 2025-12-31: from financing, $172.46M came in.
  • Fiscal year ended 2025-12-31: change in cash, $7.22M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDividendsNew shares soldOtherNot split outChange in cash
2025-12-31$48.29M-$227.97M$552.00K-$1.89M$173.80M*-$7.22M
2024-12-31$39.30M-$70.68M$853.00K-$514.00K$49.23M*$18.19M
2023-12-31$33.09M-$30.22M$579.00K$33.00K$500.00K*$3.98M
2022-12-31$9.04M-$24.24M$0.00$1.08M$0.00$11.00M*-$3.11M
2021-12-31-$18.22M-$20.12M$0.00$0.00$884.00K$42.61M*$5.15M
2020-12-31$50.20M-$41.62M-$65.00K$0.00$1.14M-$10.02M*-$359.00K
2019-12-31$9.55M-$26.46M$0.00-$11.60M$30.00K$28.84M*$361.00K
2018-12-31$23.27M-$9.48M$0.00$0.00$0.00-$13.79M*$5.00K
2017-12-31$17.25M-$16.08M$0.00$0.00-$1.16M*$6.00K

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksNew shares soldOtherNot split outChange in cash
2026-06-30$21.83M*-$39.92M*$1.16M*-$457.00K*$27.75M*
2026-03-31-$3.40M-$5.38M$1.27M-$345.00K-$4.25M*-$12.11M
2025-12-31$20.96M*-$153.02M*-$357.00K*-$689.00K*$147.80M*
2025-09-30$13.92M*-$14.60M*$79.00K*-$455.00K*-$11.00M*
2025-06-30$34.64M*-$10.05M*$438.00K*-$363.00K*-$15.50M*
2025-03-31-$21.23M-$50.30M$392.00K-$387.00K$52.50M*-$19.02M
2024-12-31$20.57M*-$4.40M*-$1.17M*-$373.00K*$5.15M*
2024-09-30$7.69M*-$33.01M*$710.00K*-$60.00K*$26.09M*
2024-06-30$10.49M*-$9.64M*$816.00K*-$92.00K*
2024-03-31$545.00K-$23.64M$493.00K$11.00K$19.25M*-$3.34M
2023-12-31$5.18M*-$12.65M*$109.00K*$10.03M*
2023-09-30$12.38M*-$6.35M*$18.00K*-$5.50M*
2023-06-30$6.54M*-$8.90M*$249.00K*$2.00M*
2023-03-31$9.00M-$2.33M$203.00K-$6.00M*$873.00K
2022-12-31-$3.93M*-$4.06M*$117.00K*$7.00M*
2022-09-30$8.07M*-$11.43M*$606.00K*$2.50M*
2022-06-30$8.97M*-$6.17M*$271.00K*-$3.50M*
2022-03-31-$4.07M-$2.58M$90.00K$5.00M*-$1.56M
2021-12-31-$5.16M*-$2.05M*$0.00*$195.00K*$8.50M*
2021-09-30-$1.26M*-$2.59M*$0.00*$176.00K*$4.50M*
2021-06-30-$4.54M*-$11.48M*$295.00K*$13.00M*
2021-03-31-$7.27M-$4.00M$218.00K$16.61M*$5.56M
2020-12-31-$2.88M*-$14.04M*$0.00*$589.00K*$8.05M*
2020-09-30$9.69M*-$13.78M*-$8.00K*$337.00K*
2020-06-30$41.31M*-$7.03M*$77.00K*-$27.06M*
2020-03-31$2.09M-$6.77M$138.00K$8.97M*$4.43M
2019-12-31-$2.64M*-$3.96M*$0.00*$30.00K*$6.93M*
2019-09-30$8.19M*-$3.94M*$0.00*$0.00*-$4.25M*
2019-06-30$5.42M*-$16.00M*$0.00*$10.59M*
2019-03-31-$1.41M-$2.56M$0.00$3.98M*$0.00
2018-12-31$7.07M*-$3.93M*-$3.14M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Omada Health, Inc. (OMDA)United States$1.207B309.08
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86